Patrick Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, and Executive Chairman of the Los Angeles Times, shared a post on X:
“There is so much data to disclose that over the next few days we will announce results with Anktiva plus checkpoints in lung cancer, results with CAR NK cell therapy including CD-19 NK in lymphoma, PDL1-NK in Glooblastoma and head and neck cancer. Multiple press releases.!”
More posts featuring Patrick Soon-Shiong on OncoDaily.